Accuray | ARAY - Operating Profit


Accuray reported $4.71M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Abbott USD 1.36B 775M Sep/2026
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 4.35M 5.31M Sep/2026
Boston Scientific USD 1.01B 232M Sep/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Inogen USD -7.79M 728K Sep/2024
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Tandem Diabetes Care USD -2.37M 11.42M Sep/2026
Trinity Biotech USD -1.79M 481K Mar/2026